Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Utc Therapeutics Inc.

Clinical trials sponsored by Utc Therapeutics Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Engineered immune cells take on Hard-to-Treat cancers Results expected Apr 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 1

Engineered immune cells take on Hard-to-Treat cancers

Disease control Recruiting now

This early study is testing a new treatment called Anti-HER2 CAR-T cells in 30 adults with advanced solid tumors that have the HER2 protein and have not responded to standard treatments. Participants first receive chemotherapy, then an infusion of the engineered immune cells. The…

Sponsor: UTC Therapeutics Inc. • Aim: Disease control

Last updated Jun 27, 2026 11:03 UTC